— Know what they know.
Not Investment Advice

PCYN OTC

Procyon Corporation
1W: +3.9% 1M: +8.0% 3M: +34.3% YTD: +123.1% 1Y: +145.4% 3Y: +12.5% 5Y: -61.4%
$0.27
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 59 · $2.2M mcap · 3M float · 0.199% daily turnover · Short 90% of daily vol

Income Trends

Revenue
$7M +33.9% ▲
5Y CAGR: +9.0%
Gross Profit
$2M -45.4% ▼
5Y CAGR: -7.8%
Operating Income
-$447K -92.7% ▼
Net Income
$34K +109.9% ▲
5Y CAGR: -21.2%
EPS (Diluted)
$0.00 +105.7% ▲
5Y CAGR: -28.0%
EBITDA
$278K +179.4% ▲
5Y CAGR: +5.4%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$5M$5M$5M$5M$7M
YoY Growth+8.9%+2.6%-3.2%+6.4%+33.9%
Cost of Revenue$1M$1M$1M$1M$5M
Gross Profit$3M$3M$4M$4M$2M
Gross Margin71.8%72.0%76.2%78.1%31.9%
R&D Expenses$31K$30K$31K$30K$30K
SG&A Expenses$3M$4M$4M$4M$3M
Operating Expenses$3M$4M$4M$4M$3M
Operating Income$227K-$237K-$97K-$232K-$447K
Operating Margin4.8%-4.9%-2.1%-4.6%-6.7%
Interest Expense$2K$0$0$0$361
Income Before Tax$734K-$235K-$65K-$171K$3K
Tax Expense$39K-$26K-$15K$170K-$31K
Net Income$694K-$210K-$50K-$341K$34K
Net Margin14.7%-4.3%-1.1%-6.8%0.5%
EPS (Diluted)$0.08$-0.03$-0.01$-0.04$0.00
EBITDA$900K-$23K$166K$99K$278K
Shares Outstanding8M8M8M8M8M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms